Digital PCR Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â ¼¼°è µðÁöÅÐ PCR ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Á¶»ç º¸°í¼´Â È«º¸ ¿äÀÎ, µ¿Çâ, ±âȸ ¹× °úÁ¦¸¦ Æ÷ÇÔÇÑ Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» »ó¼¼ÇÏ°Ô Æò°¡ÇÏ°í ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ Á¶»ç º¸°í¼´Â 2024³âºÎÅÍ 2033³â±îÁö µðÁöÅÐ PCR ½ÃÀå ¿¹Ãø ¼ºÀå ±Ëµµ¸¦ °³·«ÀûÀ¸·Î º¸¿©ÁÖ´Â µ¶Á¡ µ¥ÀÌÅÍ¿Í Åë°è¸¦ °ÔÀçÇÕ´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
½ÃÀå ±Ô¸ð(2024³â) : 1¾ï 8,380¸¸ ´Þ·¯
¿¹Ãø ½ÃÀå ¸ÅÃâ(2033³â) : 4¾ï 380¸¸ ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR(2024-2033³â)) : 9.1%
µðÁöÅÐ PCR ½ÃÀå - º¸°í ¹üÀ§:
µðÁöÅÐ PCRÀº Á¾¾çÇÐ, °¨¿°, À¯ÀüÀÚ °Ë»ç µî ´Ù¾çÇÑ ¿ëµµ¿¡¼ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ ±â¼úÀº ÇÙ»ê °ËÃâ¿¡ Ź¿ùÇÑ °¨µµ¿Í Á¤È®¼ºÀ» Á¦°øÇÏ¿© ¿¬±¸ ¹× ÀÓ»ó Áø´Ü¿¡¼ Á¤È®ÇÑ Á¤·®°ú ºÐ¼®À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. µðÁöÅÐ PCR ½ÃÀåÀº ¿¬±¸½Ç, Á¦¾à ȸ»ç, Áø´Ü¼¾ÅÍ, Çмú ±â°ü¿¡ ¼ºñ½º¸¦ Á¦°øÇÏ°í ´Ù¾çÇÑ µðÁöÅÐ PCR Ç÷§Æû°ú ¼Ò¸ðǰÀ» Á¦°øÇÕ´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:
¼¼°è µðÁöÅÐ PCR ½ÃÀåÀº °íÁ¤¹Ð ºÐÀÚÁø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ºÐ¼®ÀÇ ¹Î°¨µµ ¹× ƯÀ̼ºÀ» ³ôÀÌ´Â µðÁöÅÐ PCR ±â¼úÀÇ ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. °³ÀÎÈµÈ ÀÇ·á Á¢±Ù¹ýÀÇ Ã¤Åà Ȯ´ë, ¾×ü »ýü»ý¼º ¹× Èñ±Í ´ë¸³À¯ÀüÀÚ °ËÃâ¿¡¼ÀÇ ¿ëµµ È®´ë´Â ½ÃÀå È®´ë¸¦ ´õ¿í µÞ¹ÞħÇÕ´Ï´Ù. °Ô´Ù°¡, ºÐ»ê °Ë»ç ¹× POC(Point of Care) Áø´ÜÀ¸·ÎÀÇ ÀüȯÀº ½ÃÀå ¼ºÀå ±âȸ¸¦ °¡¼ÓÈÇÕ´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:
À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸ÇÏ°í µðÁöÅÐ PCR ½ÃÀåÀº ³ôÀº Àåºñ ºñ¿ë, º¹ÀâÇÑ ºÐ¼® °³¹ß ¿ä±¸ »çÇ×, Áø´Ü °Ë»ç¸¦ °ü¸®ÇÏ´Â ±ÔÁ¤ÀÇ º¹À⼺°ú °ü·ÃµÈ °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ºÐ¼® ¼º´ÉÀÇ ÆíÂ÷¿Í µ¥ÀÌÅÍ ºÐ¼®À» À§ÇÑ ¼÷·ÃÀÚÀÇ Çʿ伺Àº ƯÈ÷ ÀÚ¿øÀÌ Á¦ÇÑµÈ È¯°æ¿¡¼ ½ÃÀå ħÅõÀÇ Ãß°¡ À庮ÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ´Â ºÐ¼® ¼³°èÀÇ Áö¼ÓÀûÀÎ Çõ½Å, ºñ¿ë È¿À²ÀûÀÎ Ç÷§Æû °³¹ß ¹× ±ÔÁ¦ °æ·Î¸¦ °£¼ÒÈÇϱâ À§ÇÑ Àü·«Àû Á¦ÈÞ°¡ ÇÊ¿äÇÕ´Ï´Ù.
½ÃÀå ±âȸ:
µðÁöÅÐ PCR ½ÃÀåÀº ±â¼ú Çõ½Å, °Ç° °ü¸® ÁöÃâ Áõ°¡, °³ÀÎÈ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ È¯ÀÚ ¼ö¿ä Áõ°¡·Î Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. µðÁöÅÐ PCR Ç÷§Æû¿¡¼ ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº µ¥ÀÌÅÍ ºÐ¼® ´É·ÂÀ» °ÈÇϰí Áø´Ü Á¤È®µµ¸¦ Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ ºñħ½ÀÀû »êÀü °Ë»ç, °¨¿°Áõ ¸ð´ÏÅ͸µ, ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ ºÐ¼®¿¡ÀÇ ÀÀ¿ë È®´ë°¡ ½ÃÀå Àü¸ÁÀ» ³ÐÇô°¡°í ÀÖ½À´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê, R&D ÅõÀÚ, ½ÅÈï±¹ ½ÃÀå¿¡ ´ëÇÑ Áö¸®Àû È®´ë´Â ÁøÈÇÒ ±âȸ¸¦ Ȱ¿ëÇÏ°í °æÀï ¿ìÀ§¸¦ À¯ÁöÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·ç´Â ÁÖ¿ä Áú¹®
¼¼°è µðÁöÅÐ PCR ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
µðÁöÅÐ PCR ±â¼úÀÇ Ã¤¿ëÀ» ÃËÁøÇÏ´Â ¿ëµµ¿Í ÃÖÁ¾ »ç¿ëÀÚ ºÐ¾ß´Â?
±â¼úÀÇ Áøº¸´Â µðÁöÅÐ PCR ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô ¹Ù²Ù°í Àִ°¡?
µðÁöÅÐ PCR ½ÃÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ±â¾÷Àº ¾îµð¿¡¼ ½ÃÀåÀÇ ¸®´õ½ÊÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
¼¼°è µðÁöÅÐ PCR ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ°ú ¹Ì·¡¼ºÀº?
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§/ ºÐ·ù
½ÃÀåÀÇ Á¤ÀÇ/ ¹üÀ§/ Á¦ÇÑ
Æ÷ÇÔ »çÇס¤ Á¦¿Ü »çÇ×
Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä µ¿Çâ
Á¦Ç° Çõ½Å/ °³¹ß µ¿Çâ
Á¦4Àå ÁÖ¿ä ¼º°ø ¿äÀÎ
Á¦Ç° ä¿ë ºÐ¼®
½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ
±ÔÁ¦ ½Ã³ª¸®¿À
ÁÖ¿ä ÇÁ·Î¸ð¼Ç Àü·« : Á¦Á¶¾÷üº°
ÃÖ±Ù Á¦Ç° Ãâ½Ã
PESTEL ºÐ¼®
Porter's Five Forces ºÐ¼®
Á¦5Àå ½ÃÀå ¹è°æ
°Å½Ã°æÁ¦ ¿äÀÎ
¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
½ÃÀå ¿ªÇÐ
Á¦6Àå COVID19 À§±â ºÐ¼®
2024³â ½ÃÀå ½Ã³ª¸®¿À
COVID-19¿Í ¿µÇ⠺м®
Á¦Ç°º°
ÃÖÁ¾ »ç¿ëÀÚº°
¿ëµµº°
Áö¿ªº°
Á¦7Àå ¼¼°è µðÁöÅÐ PCR ½ÃÀå ¼ö¿ä(¼ö·®) ºÐ¼®
°ú°Å ½ÃÀå(¼ö·®) ºÐ¼®(2019-2023³â)
ÇöÀç ¹× ¹Ì·¡ ½ÃÀå(¼ö·®) ¿¹Ãø(2024-2033³â)
Á¦8Àå ¼¼°è µðÁöÅÐ PCR ½ÃÀå - °¡°Ý ºÐ¼®
Áö¿ªº° °¡°Ý ºÐ¼® : Á¦Ç°º°
¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©
°¡°Ý ¼³Á¤ÀÇ ÀüÁ¦Á¶°Ç
Á¦9Àå ¼¼°è µðÁöÅÐ PCR ½ÃÀå ¼ö¿ä(±Ý¾× ¶Ç´Â ±Ô¸ð, ¹é¸¸ ´Þ·¯) ºÐ¼®
°ú°Å ½ÃÀå ¸ÅÃâ(¹é¸¸ ´Þ·¯) ºÐ¼®(2019-2023³â)
ÇöÀç ¹× ¹Ì·¡ ½ÃÀå ¸ÅÃâ(¹é¸¸ ´Þ·¯) ¿¹Ãø(2024-2033³â)
Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
Àý´ë¾×ÀÇ ±âȸ ºÐ¼®
Á¦10Àå ¼¼°è µðÁöÅÐ PCR ½ÃÀå ºÐ¼® : Á¦Ç°º°
¼Ò°³/ ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(À¯´Ö) ºÐ¼® : Á¦Ç°º°(2019-2023³â)
ÇöÀç ¹× ¹Ì·¡ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(À¯´Ö)ÀÇ ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°(2024-2033³â)
½ÃÀå ¸Å·Âµµ ºÐ¼® : Á¦Ç°º°
Á¦11Àå ¼¼°è µðÁöÅÐ PCR ½ÃÀå ºÐ¼® : ¿ëµµº°
¼Ò°³/ ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼® : ¿ëµµº°(2019-2023³â)
ÇöÀç ¹× ¹Ì·¡ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°(2024-2033³â)
ÀÓ»ó Áø´Ü
±âÃÊÁ¶»ç
ÀÀ¿ëÁ¶»ç
¹ýÀÇÇÐ °Ë»ç
½ÃÀå ¸Å·Âµµ ºÐ¼® : ¿ëµµº°
Á¦12Àå ¼¼°è µðÁöÅÐ PCR ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°
¼Ò°³/ ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°(2019-2023³â)
ÇöÀç ¹× ¹Ì·¡ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°(2024-2033³â)
Á¦¾àȸ»ç
Á¶»ç±â°ü
¹ýÀÇÇÐ ¿¬±¸¼Ò
³ó¾÷±â¾÷
½ÃÀå ¸Å·Âµµ ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°
Á¦13Àå ¼¼°è µðÁöÅÐ PCR ½ÃÀå ºÐ¼® : Áö¿ªº°
¼Ò°³
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ºÐ¼® : Áö¿ªº°(2019-2023³â)
ÇöÀç ¹× ¹Ì·¡ ½ÃÀå ±Ô¸ð(¹é¸¸ ¹Ì ´Þ·¯)¿Í ¼ö·®(À¯´Ö)ÀÇ ºÐ¼®°ú ¿¹Ãø :Áö¿ªº°(2024-2033³â)
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
³²¾Æ½Ã¾Æ
µ¿¾Æ½Ã¾Æ
¿À¼¼¾Æ´Ï¾Æ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
½ÃÀå ¸Å·Âµµ ºÐ¼® :Áö¿ªº°
Á¦14Àå ºÏ¹ÌÀÇ µðÁöÅÐ PCR ½ÃÀå ºÐ¼®
Á¦15Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ µðÁöÅÐ PCR ½ÃÀå ºÐ¼®
Á¦16Àå À¯·´ µðÁöÅÐ PCR ½ÃÀå ºÐ¼®
Á¦17Àå ³²¾Æ½Ã¾ÆÀÇ µðÁöÅÐ PCR ½ÃÀå ºÐ¼®
Á¦18Àå µ¿¾Æ½Ã¾ÆÀÇ µðÁöÅÐ PCR ½ÃÀå ºÐ¼®
Á¦19Àå ¿À¼¼¾Æ´Ï¾ÆÀÇ µðÁöÅÐ PCR ½ÃÀå ºÐ¼®
Á¦20Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)ÀÇ µðÁöÅÐ PCR ½ÃÀå ºÐ¼®
Á¦21Àå ½ÃÀå ±¸Á¶ ºÐ¼®
½ÃÀå ºÐ¼® : ±â¾÷ Tierº°
ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
½ÃÀåÇöÀçºÐ¼®
Á¦22Àå °æÀï ºÐ¼®
°æÀï ´ë½Ãº¸µå
°æÀï º¥Ä¡¸¶Å·
°æÀïÀÇ »ó¼¼ Á¤º¸
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
Fluidigm Corp.
Formulatrix, Inc.
JN Medsys.
STILLA TECHNOLOGIES
Avance Bioscience
Fluidgm corporation,
jn medsys
Merck KGAA
Precigenome LLC
QIAGEN NV
Sysmex corporation.
Á¦23Àå »ç¿ëµÈ ÀüÁ¦Á¶°Ç°ú ¾à¾î
Á¦24Àå Á¶»ç ¹æ¹ý
JHS
Persistence Market Research has recently released a comprehensive report on the global Digital PCR Market. The report offers a detailed assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the digital PCR market from 2024 to 2033.
Key Insights:
Market Size (2024E): USD 183.8 Million
Projected Market Value (2033F): USD 403.8 Million
Global Market Growth Rate (CAGR 2024 to 2033): 9.1%
Digital PCR Market - Report Scope:
Digital PCR plays a pivotal role in various applications, including oncology, infectious diseases, and genetic testing. This technology offers superior sensitivity and accuracy in detecting nucleic acids, enabling precise quantification and analysis in research and clinical diagnostics. The digital PCR market serves research laboratories, pharmaceutical companies, diagnostic centers, and academic institutions, offering a range of digital PCR platforms and consumables.
Market Growth Drivers:
The global digital PCR market is driven by several factors, including increasing demand for high precision molecular diagnostics, rising prevalence of chronic diseases, and advancements in digital PCR technology enhancing assay sensitivity and specificity. Growing adoption of personalized medicine approaches and expanding applications in liquid biopsy and rare allele detection further bolster market expansion. Additionally, the shift towards decentralized testing and point-of-care diagnostics accelerates market growth opportunities.
Market Restraints:
Despite promising growth prospects, the digital PCR market faces challenges related to high instrument costs, complex assay development requirements, and regulatory complexities governing diagnostic tests. Variability in assay performance and the need for skilled personnel for data analysis pose additional barriers to market penetration, particularly in resource-limited settings. Addressing these challenges requires continuous innovation in assay design, cost-effective platform development, and strategic collaborations to streamline regulatory pathways.
Market Opportunities:
The digital PCR market presents significant growth opportunities driven by technological innovations, increasing healthcare expenditure, and rising patient demand for personalized diagnostic solutions. Integration of artificial intelligence and machine learning in digital PCR platforms enhances data analysis capabilities and improves diagnostic accuracy. Moreover, expanding applications in non-invasive prenatal testing, infectious disease monitoring, and cancer biomarker analysis broaden market prospects. Strategic partnerships, investment in research and development, and geographic expansion into emerging markets are crucial for capitalizing on evolving opportunities and sustaining competitive advantage.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the global digital PCR market?
Which applications and end-user segments are propelling adoption of digital PCR technologies?
How are technological advancements reshaping the competitive landscape of the digital PCR market?
Who are the key players contributing to the digital PCR market, and what strategies are they employing to maintain market leadership?
What are the emerging trends and future prospects in the global digital PCR market?
Competitive Intelligence and Business Strategy:
Leading players in the global digital PCR market, including major companies such as Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., and jn medsys, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest significantly in R&D to develop next-generation digital PCR platforms, expand assay portfolios, and enhance automation capabilities. Collaborations with clinical laboratories, biopharmaceutical firms, and regulatory agencies facilitate market access and drive technology adoption. Moreover, emphasis on clinical validation studies, regulatory compliance, and customer education promotes market growth and enhances diagnostic accuracy in the rapidly evolving digital PCR landscape.
Key Companies Profiled:
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
Fluidigm Corp.
Formulatrix, Inc.
JN Medsys.
STILLA TECHNOLOGIES
Avance Bioscience
Fluidgm corporation,
jn medsys
Merck KGAA
Precigenome LLC
QIAGEN N.V
Sysmex corporation
Key Segments of the Digital PCR Industry
By Product:
Instrument
Consumables
Services
By End User:
Pharmaceutical Companies
Research Institutes
Forensic Labs
Agriculture Companies
By Application:
Clinical Diagnostics
Basic Research
Applied Research
Forensic Testing
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption Analysis
4.2. New Product Launches and Approvals
4.3. Regulatory Scenario
4.4. Key Promotional Strategies by Manufacturers
4.5. Recent Product Launches
4.6. PESTEL Analysis
4.7. Porter's Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Industry Outlook
5.1.3. Global PCR Market Analysis
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Technology Advancements in diagnostic imaging
5.2.3. New Product Launches
5.2.4. Growing Geriatric Population
5.2.5. Increasing minimally invasive procedures
5.2.6. Increased Funding and Support from the Government
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. 2024 Market Scenario
6.2. COVID-19 and Impact Analysis
6.2.1. By Product
6.2.2. By End User
6.2.3. By Application
6.2.4. By Region
7. Global Digital PCR Market Demand (in Volume) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market (Volume) Analysis, 2019-2023
7.2. Current and Future Market (Volume) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Digital PCR Market - Pricing Analysis
8.1. Regional Pricing Analysis, By Product
8.2. Global Average Pricing Analysis Benchmark
8.3. Pricing Assumptions
9. Global Digital PCR Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033
9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Product, 2019-2023
10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2033
10.3.1. Instrument
10.3.2. Consumables
10.3.3. Services
10.4. Market Attractiveness Analysis, By Product
11. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis by Application, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2033
11.3.1. Clinical Diagnostics
11.3.2. Basic Research
11.3.3. Applied Research
11.3.4. Forensic Testing
11.4. Market Attractiveness Analysis, By Application
12. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
12.3.1. Pharmaceutical Companies
12.3.2. Research Institutes
12.3.3. Forensic Labs
12.3.4. Agriculture Companies
12.4. Market Attractiveness Analysis, By End User
13. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Region, 2019-2023
13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa
13.4. Market Attractiveness Analysis, By Region
14. North America Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By End User
14.3.4. By Application
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By End User
14.4.4. By Application
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Market Trends
14.8. Country-Level Analysis & Forecast
14.8.1. U.S. Digital PCR Market
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By End User
14.8.1.2.3. By Application
14.8.2. Canada Digital PCR Market
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By End User
14.8.2.2.3. By Application
15. Latin America Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. Mexico
15.3.1.2. Brazil
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By End User
15.3.4. By Application
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By End User
15.4.4. By Application
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Market Trends
15.8. Country-Level Analysis & Forecast
15.8.1. Mexico Digital PCR Market
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By End User
15.8.1.2.3. By Application
15.8.2. Brazil Surgical Imaging Market
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By End User
15.8.2.2.3. By Application
15.8.3. Argentina Digital PCR Market
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By End User
15.8.3.2.3. By Application
16. Europe Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. U.K.
16.3.1.2. Germany
16.3.1.3. Italy
16.3.1.4. France
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. BENELUX
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By End User
16.3.4. By Application
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By End User
16.4.4. By Application
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Market Trends
16.8. Country-Level Analysis & Forecast
16.8.1. U.K. Digital PCR Market
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By End User
16.8.1.2.3. By Application
16.8.2. Germany Digital PCR Market
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By End User
16.8.2.2.3. By Application
16.8.3. Italy Digital PCR Market
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By End User
16.8.3.2.3. By Application
16.8.4. France Digital PCR Market
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By End User
16.8.4.2.3. By Application
16.8.5. Spain Digital PCR Market
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast by Market Taxonomy
16.8.5.2.1. By Product
16.8.5.2.2. By End User
16.8.5.2.3. By Application
16.8.6. Russia Digital PCR Market
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast by Market Taxonomy
16.8.6.2.1. By Product
16.8.6.2.2. By End User
16.8.6.2.3. By Application
16.8.7. BENULUX Digital PCR Market
16.8.7.1. Introduction
16.8.7.2. Market Analysis and Forecast by Market Taxonomy
16.8.7.2.1. By Product
16.8.7.2.2. By End User
16.8.7.2.3. By Application
17. South Asia Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Malaysia
17.3.1.4. Thailand
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By End User
17.3.4. By Application
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By End User
17.4.4. By Application
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Market Trends
17.8. Country-Level Analysis & Forecast
17.8.1. India Digital PCR Market
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By End User
17.8.1.2.3. By Application
17.8.2. Indonesia Digital PCR Market
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By End User
17.8.2.2.3. By Application
17.8.3. Malaysia Digital PCR Market
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By End User
17.8.3.2.3. By Application
17.8.4. Thailand Digital PCR Market
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By End User
17.8.4.2.3. By Application
18. East Asia Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product
18.3.3. By End User
18.3.4. By Application
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By End User
18.4.4. By Application
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
18.7. Key Market Trends
18.8. Country Level Analysis & Forecast
18.8.1. China Digital PCR Market
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By End User
18.8.1.2.3. By Application
18.8.2. Japan Digital PCR Market
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By End User
18.8.2.2.3. By Application
18.8.3. South Korea Digital PCR Market
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By End User
18.8.3.2.3. By Application
19. Oceania Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By End User
19.3.4. By Application
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By End User
19.4.4. By Application
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
19.7. Key Market Trends
19.8. Country Level Analysis & Forecast
19.8.1. Australia Digital PCR Market
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By End User
19.8.1.2.3. By Application
19.8.2. New Zealand Digital PCR Market
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By End User
19.8.2.2.3. By Application
20. Middle East and Africa (MEA) Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By End User
20.3.4. By Application
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By End User
20.4.4. By Application
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
20.7. Key Market Trends
20.8. Country Level Analysis & Forecast
20.8.1. GCC Countries Digital PCR Market
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By End User
20.8.1.2.3. By Application
20.8.2. Turkey Digital PCR Market
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By End User
20.8.2.2.3. By Application
20.8.3. South Africa Digital PCR Market
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast by Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By End User
20.8.3.2.3. By Application
20.8.4. North Africa Digital PCR Market
20.8.4.1. Introduction
20.8.4.2. Market Analysis and Forecast by Market Taxonomy
20.8.4.2.1. By Product
20.8.4.2.2. By End User
20.8.4.2.3. By Application
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. Regional footprint of Players
21.3.2. Product footprint by Players
21.3.3. Channel footprint by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Bio-Rad Laboratories, Inc.
22.3.1.1. Company Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. Key Financials
22.3.1.5. SWOT Analysis
22.3.1.6. Key Developments
22.3.1.7. Strategy Overview
22.3.1.7.1. Marketing Strategy
22.3.1.7.2. Product Strategy
22.3.1.7.3. Channel Strategy
22.3.2. Thermo Fisher Scientific Inc.
22.3.2.1. Company Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. Key Financials
22.3.2.5. SWOT Analysis
22.3.2.6. Key Developments
22.3.2.7. Strategy Overview
22.3.2.7.1. Marketing Strategy
22.3.2.7.2. Product Strategy
22.3.2.7.3. Channel Strategy
22.3.3. Fluidigm Corp.
22.3.3.1. Company Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. Key Financials
22.3.3.5. SWOT Analysis
22.3.3.6. Key Developments
22.3.3.7. Strategy Overview
22.3.3.7.1. Marketing Strategy
22.3.3.7.2. Product Strategy
22.3.3.7.3. Channel Strategy
22.3.4. Formulatrix, Inc.
22.3.4.1. Company Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. Key Financials
22.3.4.5. SWOT Analysis
22.3.4.6. Key Developments
22.3.4.7. Strategy Overview
22.3.4.7.1. Marketing Strategy
22.3.4.7.2. Product Strategy
22.3.4.7.3. Channel Strategy
22.3.5. JN Medsys.
22.3.5.1. Company Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. Key Financials
22.3.5.5. SWOT Analysis
22.3.5.6. Key Developments
22.3.5.7. Strategy Overview
22.3.5.7.1. Marketing Strategy
22.3.5.7.2. Product Strategy
22.3.5.7.3. Channel Strategy
22.3.6. STILLA TECHNOLOGIES
22.3.6.1. Company Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. Key Financials
22.3.6.5. SWOT Analysis
22.3.6.6. Key Developments
22.3.6.7. Strategy Overview
22.3.6.7.1. Marketing Strategy
22.3.6.7.2. Product Strategy
22.3.6.7.3. Channel Strategy
22.3.7. Avance Bioscience
22.3.7.1. Company Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. Key Financials
22.3.7.5. SWOT Analysis
22.3.7.6. Key Developments
22.3.7.7. Strategy Overview
22.3.7.7.1. Marketing Strategy
22.3.7.7.2. Product Strategy
22.3.7.7.3. Channel Strategy
22.3.8. Fluidgm corporation,
22.3.8.1. Company Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. Key Financials
22.3.8.5. SWOT Analysis
22.3.8.6. Key Developments
22.3.8.7. Strategy Overview
22.3.8.7.1. Marketing Strategy
22.3.8.7.2. Product Strategy
22.3.8.7.3. Channel Strategy
22.3.9. jn medsys
22.3.9.1. Company Overview
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. Key Financials
22.3.9.5. SWOT Analysis
22.3.9.6. Key Developments
22.3.9.7. Strategy Overview
22.3.9.7.1. Marketing Strategy
22.3.9.7.2. Product Strategy
22.3.9.7.3. Channel Strategy
22.3.10. Merck KGAA
22.3.10.1. Company Overview
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. Key Financials
22.3.10.5. SWOT Analysis
22.3.10.6. Key Developments
22.3.10.7. Strategy Overview
22.3.10.7.1. Marketing Strategy
22.3.10.7.2. Product Strategy
22.3.10.7.3. Channel Strategy
22.3.11. Precigenome LLC
22.3.11.1. Company Overview
22.3.11.2. Product Portfolio
22.3.11.3. Sales Footprint
22.3.11.4. Key Financials
22.3.11.5. SWOT Analysis
22.3.11.6. Key Developments
22.3.11.7. Strategy Overview
22.3.11.7.1. Marketing Strategy
22.3.11.7.2. Product Strategy
22.3.11.7.3. Channel Strategy
22.3.12. QIAGEN N.V
22.3.12.1. Company Overview
22.3.12.2. Product Portfolio
22.3.12.3. Sales Footprint
22.3.12.4. Key Financials
22.3.12.5. SWOT Analysis
22.3.12.6. Key Developments
22.3.12.7. Strategy Overview
22.3.12.7.1. Marketing Strategy
22.3.12.7.2. Product Strategy
22.3.12.7.3. Channel Strategy
22.3.13. Sysmex corporation.
22.3.13.1. Company Overview
22.3.13.2. Product Portfolio
22.3.13.3. Sales Footprint
22.3.13.4. Key Financials
22.3.13.5. SWOT Analysis
22.3.13.6. Key Developments
22.3.13.7. Strategy Overview
22.3.13.7.1. Marketing Strategy
22.3.13.7.2. Product Strategy
22.3.13.7.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology